Citius Pharma (CTXR), Fortress Biotech (FBIO) and True Nature (TNTY) Significantly Higher on News.
Fortress Bio (FBIO, $2.42) Up 43%, Citius Pharma (CTXR, $1.15) Up 109% and True Nature Holdings (TNTY, $0.043) Up 117%, Since Adding...
Apple’s Second Chance at Romance. One That Got Away, Twice!
Charts tell the story.
True Nature|Mitesco (TNTY). Coverage Report Issued.
Record Volume and Gradually Rising Price Portends to Higher Prices in 2020 as True Nature Executes on Recently Announced Incubator Strategy.
Armistice Capital Master Fund Ltd., and Citius Pharma (CTXR).
April 2019 Offering
On April 1, 2019, Citius entered into securities purchase agreements with institutional investors and accredited investors...
“I Dare the FDA not to Approve Our Drug.”
"Woe, Woe, Woe Wait a Minute. We Meant That Biogen Respects and Appreciates the FDA Review Process.” All Hail the FDA! Biogen...
True Nature’s (TNTY) CEO Larry Diamond on Wall Street Analyzer.
Larry Diamond Reveals Some of True Nature's Goals and Ambitions to Incubate Medical Related Startups to Benefit All Shareholders.
Biotech’s Turning Up…
Biotech Sector Gains Near 10% in Past Month, After Biogen (BIIB) Reports Breaking News.
We keep telling investors...
True Nature | Mitesco (TNTY), Perking Up.
Is it too early to nick-name True Nature's Medtech incubator Mitesco the "Mighty Mitesco?" Of course it's too early - but it...
Stand Down IV: Remember This? Alta Vista Cancels IPO. David Wetherell Takes a $2...
We are going through some of our very old 'incubator files' back from when we ran the Incubator Stock Review, a spinoff...
Latest article
Adding Quantum Pharmaceutical (QNTM) $4.10 to Reverse Split Stock Watch List.
119% Gain Post Split
Nine Page Summary Report on GeoVax (GOVX)
This is a great long-term story. We’re telling you.
(March 2024) When we finished writing our earlier...
GeoVax (GOVX) Provides First Half 2024 Business Update.
Award of BARDA Project NextGen contract represents a significant milestone event;
Total value...
